Inhibition of cyclophosphomide mutagenicity using Glycyrrihza glabra root extract by Qasim M. Ali Al Ameri, Mona N. Al-Terehi, Ali H. Al Saadi and
 
Research in Pharmacy 2(3) : 32-39, 2012                                                       ISSN : 2231-539X 
www.researchinpharmacy.com 
 
 
 
Regular Article 
Inhibition of cyclophosphomide   mutagenicity using 
Glycyrrihza glabra root extract 
 
1Mona N. Al-Terehi, 2Ali H. Al Saadi and 3Qasim M. Ali Al Ameri 
 
1College of Science, Kufa University; 2College of Science, University of Babylon;  3College of 
Pharmacy, University of Babylon 
 
          The aims of the studying is using methanolic - water extract of the Glycyrrihza glabra 
root for inhibition the mutagenicity of anticancer drug by cytogenetic assays in vivo in three 
interaction between the drug and extract. The result shows that the extract is bio-
antimutagenesis. The treatment by extract after drug causes increase mitotic index and 
decrease chromosome aberration and sperm head abnormalities. The thin layer 
chromatography of the extract show that is contains different polar compounds.                     
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DNA is one of the important cell cotenants, it is affecting by physiological, chemical  and 
biological agents that causes increase in mutation rates and rearrangement of chromosomes and 
induced different type of chromosome aberration (1) the effects of this agents interact with the 
types, quantity and the exposure to it, so the metabolic amount and its effect on genetic material 
and repair system enzyme ability to remove this effect (2). Glycyrrihza glabra (GLY) is one of the 
plant that have long historical in medical and therapeutic use since Babylon and Egyptian 
revolution (3). The studying show Glycyrrihza glabra have wide range of phytochemical 
compounds like terpenoid saponine, phenols, volatile oils, vitamins, minerals, sterols, protein, 
sugars and starch (4). The research improved the ability of Glycyrrihza glabra as anti mutagens 
(5) show that GLY extract was anti mutagenic to spontaneous and induced mutation in specific 
locus in genome by chemical factors such as EMS and nitrofurzene using aims and rec assay, so 
the antimutagenesity of this plant in induced mutation in Salmonella spp. by EMS that it have 
18-α glycyrrhizin and 18-β glycyrrhizin. 
   Cyclophosphamide is anticancer drug, alkalating agent that interfere with 
transcription and translation of nucleic acid as a result this effect on cell proliferation, it has 
been used as mutagenicity factor in wide range of experiments. 
   
Materials and method  
Plant extract : It was prepared according to Sato et al. (9) with modification, powder root 
homogenized with solvent extract contain from (methanol : DW) (20:80 V\V) in blander for 30 
min then it filtered and deride in oven 50Cº for 24 hour then it keep in dim container.   TLC 
profile according to (10) using solvents system (chlorophorm : hexan: ethanol) (1:1:1v\v\v). 
Mutagenic factor: using cyclophosphamide tablet, dose was 20 mg\kg. 
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Cytogenetic assay: using chromosome aberration assay, mitotic index assay and sperm head 
abnormalities assay. 
Experimental design : Using white albino rats (male) in Wight 300 ± 50 and age 10 ± 2 weeks 
was divided in to 5 groups: 
1- Group treated by cyclophosphomide 20 mg\kg. Animal killed after 24 hours  
2-  Group treated by plant extract 500, 250 mg\kg. Animal killed after 24 hours. 
3- Group treated by DW as negative control 
4- Group treated extract before drug. Animal killed after 48hours              
5-  Group treated extract with drug.  Animal killed after 24hours  
6-  Group treated extract after drug. Animal killed after 48 hours 
After finished treatment animals was killed, cytogenetic assays was performed 
Chromosome aberration and mitotic index : according to (11)  with some modification, after 
animal killed femur bone was cleaned  the bone end was cut then bone marrow discard by 
hypotonic solution (KCl 0.05 M) in test tube then it keep it in 37°C for 15 min with shaking after 
this it centrifugation 2000 rpm to 2 min, discard supernatant  and the sedimentation was 
fixation by fixative solution  (methanol : glacial acetic acid ) (3:1) then centrifugation 2000 rpm 
for 2 min, repeat fixation 2 time, at last fixation step sample was distil on cold slide above 75 cm, 
after dried slide can stained it  using gemza stain for determination chromosome aberration and 
mitotic index (13).  
Sperm head abnormality: This performed from epididymis, it cutting in phosphate buffer 
saline then one drop transfer to slide after dried it fixative by drops of methanol then stand by 
methylene blue for exam sperm head abnormality (12).      
Statistics: using one way ANOVA in probability p<0.05 by SPSS software. 
 
Results and dissection  
TLC profile  
The TLC results  in table 1 and figure 1show that extract contain from different polar compound 
by using visible light and UV light (WL 312n) in other researchers found that GLY contain from 
comarins, isoflavons such as glabrone and glabrene (14) so they improved that the stolen and 
root of this plant have large number of phenolic compounds like formonotin, glabridin, 
isoliquirtigenin, hemileicarpin, paratocarpin and  hispaglabridin  B so the root have high 
percentage of (GA) glabridin if it extracted by  solvents mixture (ethanol : DW) ( 70:30 v\v).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. TLC profile of GLY extract 1n visible light A, and UV light B. 
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Table 1. Band characters of the TLC profile of GLY extract 
 
Examining Bands characters Bands number 
 
Visible light 
Color Rf  
 
2 
pink 0.34 * 
Brown 0.90 
 
UV   light 
orang 0.34 *  
7 Brown 0.37 
blue 0.51 
Violet 0.53 
brown 0.69 
Violet 0.81 
brown 0.87 
*bands found in visible and UV 
 
Chromosome aberration assay 
The results of this assay that in figure (2) and table (2) show increase in chromosome aberration 
in drug treatment in all type of it that explanation in figure 5 and decreased in interfere drug 
with plant extract in all treatment but this decreased is different  according to interfere. The 
reason of this increase was the drug causes harmful effects on   DNA it causes break in single 
and double strand, the research improved the drug was carcinogenetic and induced sister 
chromatid exchange, chromatid and chromosome break. So it induced micronuclei formation. 
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Figure 2. Percentage of chromosome aberration in bone marrow cell of rats  treated by CP and 
GLY. 
1-animals treated by DW; 2- CP treatment; 3,4- GLY treatment in 250 and 500 mg\kg 
respectively;  5,6- treatment GLY with CP in 250,500 mg\kg respectively;  7,8- treatment GLY 
before CP in 250, 500 mg\kg respectively; 9,10- treatment GLY after CP in 250, 500 mg\kg 
respectively 
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Table 2. Chromosome aberration type of rats bone marrow cell treated by CP and GLY. 
 
Me±Se        * significant at p<0.005;                    ** significant at p<0.001 
 
The aim of these interfering between plant extract an drug is for determination the how 
that extract can protect the cellular compound against the effect of mutagenicity the result in 
table 2 show that treatment after drug was the best specially in 500 mg\kg thus the GLY was 
bio-antimutagenesis this mean that extract may be increased the DNA replication fidelity or 
induced repair system enzyme as result decreased in mutation frequency (17). Gly extract 
contain of phytochemicals can be protect cell component, other research improved that extract 
causes decrease in chromosome aberration in mice bone marrow cell that treatment by chemical 
and physical factors so the extract induced repair system or phytochemical may interfere with 
mutagenicity but the mechanism of this has been unknown(19). 
 
Mitotic index assay  
Table (3) and figure (3) show the results of bone marrow proliferation that effected by 
CP treatment and GLY extract, CP causes decreased in MI because it inhibit cell division by its 
effect on DNA in S phase or by DNA -DNA cross link  or DNA – protein cross link , this 
crosslink interfere with DNA replication and transcription thus it causes stopped in cell divided 
(20) when treatment by extract with CP it causes increased in MI  especial in treatment after 
drug , this can be clarified that extract have ability to effect on cell proliferation rate when use 
different extraction method of Glycyrrihza uralensis on cell in vitro , the water and alcohol extract 
causes increased in MI by increase nucleic proteins and stimulating DNA polymerase for DNA 
replication thus its reflect on cell proliferation so this extract especially ethanolic extract 
stimulated estrogen independent cell proliferation, ethyl acetate that contain of mid polar 
compound large effect in cell division by induced proliferating cell nuclear antigen in S phase 
an G2  phase that consider as cell proliferation (21). 
 
Chromatid 
break 
Chromosome 
break Aneuploidy Polyploidy Analytical Ring Breaking 
Treatment 
mg\kg 
* 
17.00 ± 1.00 
 
9.33±1.33 
* 
8.00±2.30 
 
4.00±2.30 
 
0.00 
*6.66±3.52 ** 
1.33±1.33 
 
N C 
 
146.66 ±24.6 
 
25.33±6.66 
 
425.33±144.11 
 
2.66±2.6 
 
48.33±27.95 
 
50.66±15.02 
 
70.66±30.66 
Cp           20 
* 
10.00±3.46 
 
4.00±0.00 
* 
12.33±0.33 
 
4.00±0.57 
 
8.00±3.30 
* 
10.00±1.15 
** 
14.00±1.15 
Gly       500 
* 
12.00±0.57 
** 
2.00±1.15 
* 
12.00±1.15 
 
4.00±0.57 
 
4.00±2.30 
* 
8.00±2.30 
** 
10.00±3.43 
Gly        250 
** 
109.33±7.42 
 
26.66±1.33 
 
276.00±29.48 
 
2.66±1.33 
** 
168.00±58.56 
** 
17.33±3.52 
 
94.66±10.41 
Before   
500 
 
125.33±13.13 
 
29.33±7.05 
** 
236.00±70.31 
 
0.00 
** 
136.00±46.13 
** 
21.33±5.81 
 
97.33±12.71 
Before   
250 
 
121.33±10.91 
 
22.66±10.66 
 
286.66±31.18 
 
5.33±1.33 
 
74.00±17.08 
** 
22.66±8.11 
 
62.66±11.85 
With   
500 
** 
100.00±4.00 
 
18.66±8.74 
** 
239.33±76.87 
 
5.33±1.33 
 
53.33±22.43 
** 
21.33±1.33 
 
69.33±40.68 
With   
250 
* 
37.33±13.13 
 
16.00±12.22 
* 
70.66±17.93 
 
5.33±3.52 
 
17.33±2.66 
* 
14.66±4.80 
 
34.66±1.33 
After     500 
* 
81.33±15.37 
 
40.00±11.54 
* 
72.00±8.32 
 
2.66±2.66 
 
62.66±31.35 
** 
16.00±6.11 
 
112.00±25.45 
After     250 
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Table 3. Mitotic index of rats bone marrow cell treated by CP and GLY 
Treatment Mg\kg M ± SE 
N C *5.06 ±0.57 
Cp           20 1.40±0.49 
Gly       500 5.53±0.49 
Gly        250 5.20±0.34 
Before    500 1.56±0.44 
Before    250 1.36±0.34 
With      500 1.73±0.83 
With      250 1.80±0.46 
After     500 *6.06±0.43 
After     250 *4.76±0.17 
*Significant at p<0.001   
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Figure 3. Mitotic index value of rats bone marrow that treated by CP and GLY 
1- Animals treated by DW, 2 – CP treatment; 3,4 – GLY treatment in 250 and 500 mg\kg 
respectively; 5,6- treatment GLY with CP in 250,500 mg\kg respectively; 7,8- treatment GLY 
before CP in 250 , 500 mg\kg respectively 
 
Sperm head abnormalities 
The treatment by CP causes  increased in the abnormality of sperms heads that is 
explanation in table 4 and figure 4 the reasons of this that CP is alkylating agent changes in 
DNA and induced chromosome aberration in germ cell (22) . when interfered drug and plant 
extract the results are same in all assays that use in our studying  and the mechanism of plant 
extract protection was identical, the reasons of the decrees in abnormalities was that extract 
effect on hormones that responsible of testes functions or regulatory of protein synthesis and 
repair system of germ cells, by this mechanism clarified the Chelidonium majus ability in 
decreased malformation of sperm head, so the decreased may be because the interfere or link 
between phytochemical compound  with drug such as thyme with gemcitabine(21). 
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Figure 4. Sperm head abnormality in rats treated by CP and GLY 
1 -animals treated by DW,  2 – CP treatment; 3,4 – GLY treatment in 250 and 500 mg\kg 
respectively;  5,6- treatment GLY with CP in 250,500 mg\kg respectively;  7,8- treatment GLY 
before CP in 250 , 500 mg\kg respectively. 
 
        
 
  
 
  
           
                                                                
 
 
 
 
                                                                                          
 
 
 
    
   
  
 
 
                                                                                    
 
 
Figure 5. Chromosome aberration in bone marrow cell and abnormality in sperm head  in 
rats that treated by cyclophosphamide and plant extract. A, polyploidy ; B, aneuploidy ; C, 
chromatids break ; D , chromosome break ; E, analytical ; F, breaking ; G, ring ; H, lubeled head ; 
I, curved head ; J, missed head ; k, globular head. 
 
A B C D
E F G
H I G K
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Table 4. Sperm head abnormality in rats treated by CP and GLY 
         
Missed head Lobule head Curved head Globular head Treatment 
*14.66±2.18 **2.66 ± 1.33 **0 **1.00 ± 0.57 N.C  DW 
138.33±44.75 47.00 ± 35.59 6.00 ± 1.15 11.33 ± 6.35 CP     20 
**15.33±1.20 **1.33 ± 0.66 **0.33 ± 0.33 **0.66 ± 0.33 Gly    500 
*10.33±1.45 **2.66 ± 1.45 **0 **0.66 ± 0.66 Gly    250 
97.66±11.79 17.33 ± 11.14 1.00 ± 0.57 6.33 ± 2.18 Before   500 
124.66±37.82 43.66 ± 17.37 6.00 ± 1.15 17.66 ± 4.97 Before  250 
75.33±38.76 10.33 ± 8.83 6.66 ±5.69 **2.00 ± 1.15 With  500 
**42.00±5.50 **5.33 ± 1.66 **0 **1.66 ± 0.33 With  250 
**19.66±2.33 **6.66 ± 4.25 **0 **1.00 ± 0.57 After  500 
**49.33±4.33 12.66 ± 0.33 2.33 ± 0.33 5.66 ± 3.17 After  250 
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